Mesirow Financial Investment Management, Inc.
Position in IDXX — Idexx Laboratories Inc /De
CIK 1469475
CHICAGO, IL
Position in IDXX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$207,943
-$24,117 QoQ
Shares Held
395
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,016
of 1,286 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Mesirow Financial Investment Management, Inc. holds $55,762,910 across 6 Diagnostics & Research names. IDXX ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
91,809 | $46,029,360 | |
| 2 | NTRA |
Natera, Inc.
|
23,165 | $6,288,139 | |
| 3 | DHR |
Danaher Corp /De/
|
13,304 | $2,534,145 | |
| 4 | WAT |
Waters Corp /De/
|
1,139 | $427,170 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,079 | $276,153 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
This page
|
395 | $207,943 |
All Filings in IDXX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,943 | 395 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $232,060 | 413 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $299,026 | 442 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $343,722 | 538 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $286,941 | 535 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||